Yahoo
NasdaqCM - Delayed Quote USD

Chemomab Therapeutics Ltd. (CMMB)

1.1800 +0.0200 (+1.72%)
At close: 4:00:01 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
7,909
9,567
14,739
25,459
28,533
Operating Income
-7,909
-9,567
-14,739
-25,459
-28,533
Net Non Operating Interest Income Expense
356
572
794
1,238
353
Pretax Income
-7,553
-8,995
-13,945
-24,221
-28,180
Tax Provision
0
0
0
0
-534
Net Income Common Stockholders
-7,553
-8,995
-13,945
-24,221
-27,646
Diluted NI Available to Com Stockholders
-7,553
-8,995
-13,945
-24,221
-27,646
Basic EPS
-0.96
-1.44
-3.44
-8.24
-9.68
Diluted EPS
-0.96
-1.44
-3.44
-8.24
-9.68
Basic Average Shares
7,500.6820
6,377.8460
4,058.1220
2,937.4860
2,844.8660
Diluted Average Shares
7,500.6820
6,377.8460
4,058.1220
2,937.4860
2,844.8660
Rent Expense Supplemental
51
60
50
81
24
Total Expenses
7,909
9,567
14,739
25,459
28,533
Net Income from Continuing & Discontinued Operation
-7,553
-8,995
-13,945
-24,221
-27,646
Normalized Income
-7,553
-8,995
-13,945
-24,221
-27,646
Interest Income
--
572
794
1,238
--
Net Interest Income
356
572
794
1,238
353
EBIT
-7,909
-9,567
-14,739
-25,459
-28,533
EBITDA
-7,851
-9,497
-14,686
-25,392
-28,475
Reconciled Depreciation
58
70
53
67
58
Net Income from Continuing Operation Net Minority Interest
-7,553
-8,995
-13,945
-24,221
-27,646
Normalized EBITDA
-7,851
-9,497
-14,686
-25,392
-28,475
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 2/12/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: